11 okt: Mermaid Technology - Positiv ordreindgang, opjustering og organis..
14 okt: 7 Cool Fund
13-10-2010 10:20:05

Ad hoc reports in accordance with section 15 of the German Securities Trading Act (WpHG) - Dräger raises 2010 guidance

Drägerwerk AG & Co. KGaA /

Ad hoc reports in accordance with section 15 of the German Securities Trading

Act (WpHG) - Dräger raises 2010 guidance

Processed and transmitted by Thomson Reuters.

The issuer is solely responsible for the content of this announcement.

For fiscal year 2010, Dräger is expecting an increase in net sales in the range of 10 percent (net sales 2009: EUR 1,911 billion). Net of currency effects, growth would then be in the mid single-digit range. After the company increased the forecast for the EBIT margin in June 2010 from originally 5 to 6 percent up to 7 to 8 percent, Dräger is now expecting an EBIT margin of 8 to 9 percent. As the cash settled option was replaced by an equity settled option on August 30, 2010, the impact from the Siemens cash option component has now been determined at EUR 11.8 million and is now included in this new guidance. The option component will not impact earnings in the future.

 

Now increased expectations for net sales and earnings are attributable to unexpectedly strong order intake, the unchanged positive development in the Americas and Asia-Pacific as well as favorable currency effects. The continuingly large share of high-margin equipment business in the medical division is a main contributor to higher profitability. The turnaround program is also having a highly positive effect and according to current estimates will contribute at least EUR 100 million to net earnings in 2010 against 2008. Originally the plan was to achieve a positive earnings effect of around EUR 70 million net in the current fiscal year and about EUR 100 million from 2011 on.

 

For 2011, Dräger intends to invest more into R&D, to implement projects more quickly and in particular to improve the marketing and sales organization. The company also assumes that one-time effects from the fiscal year 2010 will not recur. These include high levels of orders on hand from the previous year, strong order intake from large-scale projects, the sale of a deep-sea diving system for which an impairment charge was recorded for the full amount in 2009, the sale of software rights as well as the exceptionally advantageous product mix. External factors such as exchange rates are probably not going to benefit business in 2011 to the same degree. For 2011, Dräger is therefore not expecting to exceed the EBIT margin of the fiscal year 2010 amid slightly higher net sales. In the medium-term, the company is planning to grow stronger than the market and to achieve a sustained EBIT margin of at least 10 percent.

 

 

Drägerwerk AG & Co. KGaA

Moislinger Allee 53-55

23558 Lübeck, Deutschland

www.draeger.com

 

Investor Relations:

Vanina Herbst

Tel. +49 451 882-2685

vanina.herbst@draeger.com

 

Corporate Communications:

Burkard Dillig

Tel. +49 451 882-2185

burkard.dillig@draeger.com

 

 

Disclaimer

This ad-hoc release contains forward-looking statements regarding the future development of the Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to it to date and have been prepared to the best of its knowledge and belief. No guarantee or liability for the occurrence of the future developments and results specified can be assumed in respect of such forward-looking statements. Rather, the future developments and results are dependent on a number of factors. They entail risks and uncertainties beyond the Company's control and are based on assumptions which could prove to be incorrect. Notwithstanding any legal requirements to adjust forecasts, we assume no obligation to update the forward-looking statements contained in this report. You will find all other financial dates on our website at www.draeger.com under Investor Center/Financial Calendar.

HUG#1451547

Press release (PDF)

--- End of Message ---

Drägerwerk AG & Co. KGaA

Moislinger Allee 53-55 Lübeck Germany

Listed: Freiverkehr in Börse Stuttgart,

Prime Standard in Frankfurter Wertpapierbörse,

Regulierter Markt in Frankfurter Wertpapierbörse,

Regulierter Markt in Bayerische Börse München,

Regulierter Markt in Börse Berlin,

Regulierter Markt in Hanseatische Wertpapierbörse zu Hamburg,

Regulierter Markt in Börse Düsseldorf,

Regulierter Markt in Niedersächsische Börse zu Hannover;

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Drägerwerk AG & Co. KGaA via Thomson Reuters ONE

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
24 aug
FING-B
Sig mig.. har du slet ingen skam i livet !!.. du stjæler ENDNU ENGANG et skriv fra en anden skribent..
21
23 aug
BAVA
Bavarian Nordic har sammen med Crucell og div. myndigheder igangsat to interessante nye forsøg med M..
18
20 aug
MAERSK-B
Jeg har gravet mig ind i 6-8 oil projekter, der vil tjene Maersk Oil fra 2016 og frem, og Johan Sver..
17
24 aug
ZEAL
I Solothum uden for Bern i Svejts ligger en fabrik, hvor der er blevet investeret 50 mio CHF det sen..
16
21 aug
ZEAL
Bølgerne har gået højt her på EI’s forum siden Sanofi fredag oplyst at et mere endeligt svar på sags..
15
23 aug
DANSKE
Tro ikke på 6212 han er blot en bondeknold, der efterhånden er gået kold arme stakkels lille trold, ..
14
23 aug
 
http://borsen.dk/nyheder/politik/artikel/1/330221/opgoerelse_viser_nye_milliarder_tabt_til_skattesvi..
13
19 aug
GEN
jeg HAR selv Genmab - så er det på plads.   -------------------   Ganske kort mener jeg noget i stil..
13
24 aug
GEN
Patientgrundlaget er vurderet til at være ca. 20.000 patienter i US plus de 5 største lande i EU for..
11
23 aug
HMGLF
Baggrund:Prisen på kontrakt-lithium har været jævnt stigende i mindst 10 år, men i Kina steg spotpri..
11

Glunz FY: Ingen udbytte i vente efter ventet underskud

25-08-2016 15:09:39
Der var underskud på bundlinjen for Glunz & Jensen, der blandt andet laver og sælger udstyr til trykkerier, i det netop overståede regnskabsår, der løb fra 1. j..

Alm. Brand/CEO: Tre årsager til samlet opjustering

25-08-2016 13:00:16
Alm. Brand-koncernen kunne i torsdag morgens regnskab for andet kvartal opjustere forventningerne til hele årets resultat før skat med 100 mio. kr.Langt største..

ATP/CEO: Dong Energy skæppede med 2,9 mia. kr. - NY

25-08-2016 11:06:43
Pensionsgiganten ATP fik i første halvår et investeringsafkast på 6,7 pct. svarende til 6,9 mia. kr. Mens man tabte på udenlandske aktier - de japanske især - s..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Zealand H1: Venter bedste år nogensinde med bredere portefølje
2
Aktier/tendens: Strøm af regnskaber ventes at dominere
3
Parken/Nordnet: Aktien kan stige tocifret efter opjustering
4
Aktier/middag: Regnskabsvrimmel med plus til Sydbank
5
Veloxis' flytning til USA koster nedjustering

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. august 2016 18:40:23
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160823.1 - EUROWEB6 - 2016-08-25 18:40:23 - 2016-08-25 18:40:23 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x